Fred Alger Management’s Filana Therapeutics FLNA Stock Holding History

Fred Alger Management’s Portfolio FLNA Stock Details FLNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-10,000	Closed	-$41K	–	586
2020 Q1	$41K	Buy	+10,000	New	+$66.2K	﹤0.01%	422

Other funds holding FLNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Fred Alger Management's FLNA Position: Q2 2020 in Review

Fred Alger Management sold out of Filana Therapeutics (FLNA) in Q2 2020, closing a stake of 10,000 shares — an estimated $41K sold.

Fred Alger Management first reported a position in FLNA in Q1 2020 and held it in 1 quarter. The position peaked at $41K in Q1 2020. 51 funds tracked by Wall St. Rank hold FLNA as of Q2 2020.

Fred Alger Management reported no remaining Filana Therapeutics position as of Q2 2020 after selling out during the quarter.
Fred Alger Management sold 10,000 Filana Therapeutics shares in Q2 2020, an estimated $41K.
Fred Alger Management first reported a position in Filana Therapeutics in Q1 2020 and held it in 1 quarter.
Fred Alger Management's Filana Therapeutics position peaked at $41K in Q1 2020.
51 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2020.

Based on Fred Alger Management's 13F filing for Q2 2020, filed 14 Aug 2020.